Home / Mosaic

Novartis earnings dip on higher costs

China Daily | Updated: 2009-07-17 08:04

Novartis earnings dip on higher costs

GENEVA: Drug maker Novartis AG yesterday posted a 10 percent drop in second quarter net profit due to shifts in currency values and higher financing costs, but said underlying growth was boosted by advances in its pharmaceuticals division.

The profit of $2 billion was down from $2.3 billion in the same period of 2008, but the Basel-based company said its pharmaceuticals division performed well.

"I am pleased that our pharmaceuticals business continues to deliver double-digit underlying growth, driven by the strong momentum of our recently launched products," said Chief Executive Daniel Vasella.

Novartis earnings dip on higher costs

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349